What is Bruker's long term notes and loans?

Bruker (BRKR) reported long term notes and loans of $1.65B in Q1 2026.

How has Bruker's long term notes and loans changed year-over-year?

Bruker's long term notes and loans decreased by 21.1% year-over-year, from $2.1B to $1.65B.

What is the long-term trend for Bruker's long term notes and loans?

Over 4 years (2021 to 2025), Bruker's long term notes and loans has grown at a 8.6% compound annual growth rate (CAGR), from $1.33B to $1.85B.

Bruker BRKR Long Term Notes And Loans

Other financials

Income statement

See full

Revenue$823.4M+2.7%

Gross profit$379.8M-2.9%

Operating income$10.2M-67.9%

Net income$14.4M-17.2%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$137.6M-26.7%

Total debt$1.7B-20.9%

Total equity$2.5B+34.6%

Total assets$6.1B+3.3%

Cash flow

See full

Operating cash flow$71.2M+9.5%

CapEx$24.2M-6.9%

Free cash flow$47.0M+20.5%

Valuation

See full

Market cap$8.71B-13.2%

Enterprise value$10.25B-14.9%

P/S2.5×-0.4×

Profitability

See full

Gross margin45.3%-3.7pp

Operating margin1.3%-5.0pp

Net margin-0.6%-10.0pp

FCF margin1.5%-3.6pp

Returns & leverage

See full

Return on equity-1%-21.2pp

Debt / equity0.7×-0.5×

Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:LongTermNotesAndLoans.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's long term notes and loans.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bruker's long term notes and loans?: Bruker (BRKR) reported long term notes and loans of $1.65B in Q1 2026.
How has Bruker's long term notes and loans changed year-over-year?: Bruker's long term notes and loans decreased by 21.1% year-over-year, from $2.1B to $1.65B.
What is the long-term trend for Bruker's long term notes and loans?: Over 4 years (2021 to 2025), Bruker's long term notes and loans has grown at a 8.6% compound annual growth rate (CAGR), from $1.33B to $1.85B.